Search

everythinglearnresearchcommunity

for

Search:↓

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Treatment with methotrexate and prednisolone led to complete hair regrowth and no relapse for 2 years.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

DCPA is a chronic skin condition affecting the legs, often misdiagnosed, and needs more research for better understanding and treatment.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

Hair transplants for male baldness can show inflammation and fibrosis, but more research is needed to confirm LPP presence.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Platelet-rich plasma may not be very effective for bone healing and hair growth due to a substance it contains that blocks these processes.

The document concludes that a woman has both Frontal Fibrosing Alopecia and Lichen Simplex Chronicus, a previously unreported combination of conditions.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Trichoscopy is a useful tool for diagnosing hair disorders without pulling out hair.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

New biopsy techniques and tools improve alopecia diagnosis, and both too much and too little selenium can cause hair loss.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

The back of the scalp has more nerve fibers than the front, which may explain why some people feel more sensitivity there.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

Transverse scalp sections are better for diagnosing non-scarring hair loss, while vertical sections are better for a specific scarring hair loss called lichen planopilaris.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

Transverse scalp biopsies are more accurate for diagnosing non-cicatricial alopecia, but examining both types is best for accuracy.

Scalp massages may help stabilize or regrow hair in people suffering from hair loss, regardless of age, gender, or use of other treatments.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Scalp needle mesotherapy can effectively treat hair loss and improve hair growth.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.